Lexicon Pharmaceuticals Earnings Estimate

By analyzing Lexicon Pharmaceuticals' earnings estimates, investors can diagnose different trends across Lexicon Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Lexicon Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options. Lexicon Pharmaceuticals is projected to generate -0.065 in earnings per share on the 31st of March 2026. Lexicon Pharmaceuticals earnings estimates show analyst consensus about projected Lexicon Pharmaceuticals EPS (Earning Per Share). It derives the highest and the lowest estimates based on Lexicon Pharmaceuticals' historical volatility. Many public companies, such as Lexicon Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Lexicon Pharmaceuticals' earnings estimates, investors can diagnose different trends across Lexicon Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to rise to 1.18 in 2026, whereas Gross Profit is likely to drop slightly above 24.4 M in 2026. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexicon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.